Paper42913630PubMed
Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade.
Patra D and 17 others. Cell, 2026.
Cite this record
ConductScience Library. Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade. Papers, record 42913630. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42913630
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade.
- Journal
- Cell
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-06
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 CA263850 | NCI NIH HHS | United States | R35CA263850 | PubMed | NIH RePORTER |
| DP2 AI177967 | NIAID NIH HHS | United States | DP2AI177967 | PubMed | NIH RePORTER |
| P30 CA047904 | NCI NIH HHS | United States | P30CA047904 | PubMed | NIH RePORTER |
| R01 AI171483 | NIAID NIH HHS | United States | R01AI171483 | PubMed | NIH RePORTER |
| P50 CA121973 | NCI NIH HHS | United States | P50CA121973 | PubMed | NIH RePORTER |
| R01 CA277473 | NCI NIH HHS | United States | R01CA277473 | PubMed | NIH RePORTER |
| P50 CA097190 | NCI NIH HHS | United States | P50CA097190 | PubMed | NIH RePORTER |
| R01 AI166598 | NIAID NIH HHS | United States | R01AI166598 | PubMed | NIH RePORTER |
| S10 OD032265 | NIH HHS | United States | S10OD032265 | PubMed | NIH RePORTER |
| S10 OD032141 | NIH HHS | United States | S10OD032141 | PubMed | NIH RePORTER |
| S10 OD023402 | NIH HHS | United States | S10OD023402 | PubMed | NIH RePORTER |
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29255057 | Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/29255057 | PubMed |
| 2 | 33631227 | Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis. | J Hepatol | 2021 | https://conductscience.org/library/papers/33631227 | PubMed |
| 3 | 32603654 | Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy. | Cell | 2020 | https://conductscience.org/library/papers/32603654 | PubMed |
| 4 | 34986285 | Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. | N Engl J Med | 2022 | https://conductscience.org/library/papers/34986285 | PubMed |
| 5 | 39675428 | Frequency and Consequences of Immune Checkpoint Inhibitor-Associated Inflammatory Changes in Different Organs: An Autopsy Study Over 13 -Years. | Mod Pathol | 2025 | https://conductscience.org/library/papers/39675428 | PubMed |
| 6 | 35115705 | Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. | Nat Med | 2022 | https://conductscience.org/library/papers/35115705 | PubMed |
| 7 | 27718784 | Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27718784 | PubMed |
| 8 | 34895481 | HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/34895481 | PubMed |
| 9 | 27745970 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. | Cell | 2016 | https://conductscience.org/library/papers/27745970 | PubMed |
| 10 | 36600271 | Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/36600271 | PubMed |
| 11 | 34239137 | Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. | Nat Med | 2021 | https://conductscience.org/library/papers/34239137 | PubMed |
| 12 | 21084662 | Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. | J Immunol | 2010 | https://conductscience.org/library/papers/21084662 | PubMed |
| 13 | 38108398 | Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation. | Cancer Immunol Res | 2024 | https://conductscience.org/library/papers/38108398 | PubMed |
| 14 | 26282644 | Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/26282644 | PubMed |
| 15 | 36720857 | Host-microbe co-metabolism via MCAD generates circulating metabolites including hippuric acid. | Nat Commun | 2023 | https://conductscience.org/library/papers/36720857 | PubMed |
| 16 | 36309208 | Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy. | Gastroenterology | 2023 | https://conductscience.org/library/papers/36309208 | PubMed |
| 17 | 26872697 | Interleukin-35 Limits Anti-Tumor Immunity. | Immunity | 2016 | https://conductscience.org/library/papers/26872697 | PubMed |
| 18 | 33571254 | A novel mouse model for checkpoint inhibitor-induced adverse events. | PLoS One | 2021 | https://conductscience.org/library/papers/33571254 | PubMed |
| 19 | 23913274 | Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. | Nature | 2013 | https://conductscience.org/library/papers/23913274 | PubMed |
| 20 | 22254078 | Folate production by probiotic bacteria. | Nutrients | 2011 | https://conductscience.org/library/papers/22254078 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42913630
GET https://conductscience.org/api/papers/v1/42913630/references?page=2